NVAX Competitors & Alternatives
Compare Novavax Inc with similar stocks in the same industry
Biotechnology
NVAX
Main Stock$11.01
Tradestie Score
45
Market Cap
$1.54B
Revenue Growth
-0.8%
Analyst Upside
+29.2%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NTLA
Intellia Therapeutics, Inc
|
$11.65
|
$2.01B | - | 58 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$31.43
|
$1.97B | - | 56 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$6.48
|
$1.92B | - | 61 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$61.56
|
$1.92B | - | 57 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$38.86
|
$1.90B | 26.2 | 52 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$31.20
|
$1.84B | - | 58 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$32.09
|
$1.81B | - | 34 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$12.24
|
$1.78B | - | 54 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$16.07
|
$1.78B | - | 53 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$149.13
|
$1.77B | - | 58 | Compare |
More NVAX Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2836)
222 stocks in this industry